Infant Bacterial Therapeutics AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Staffan Strömberg, was filed 03 Jun 2022.
Infant Bacterial Therapeutics AB: what insiders have been doing
Infant Bacterial Therapeutics AB belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. Between 3 November 2025 and 3 November 2026, 2 insiders published 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
With 2 filings in twelve months, the company is quieter than the median of 9 filings across the 1,032 companies we follow on the same exchange. Looking back to 2017, when coverage begins, insiders filed 23 purchases and 10 sales.
Over the last twelve months, not one insider purchase of Infant Bacterial Therapeutics AB stock was filed.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Financial data
as of FY 2025FY ended December 2025 · cache
- 65,000 shares0OptionISIN SE0008015259FI:csv-56536233f62569b3ce36
- 32,500 shares0OptionFI:csv-49b3e475332f4d278349
- 120,000 shares@ SEK 7.009.5% of flowTeckningsoptionISIN SE0008015259FI:csv-33a3e46d8978dcc5278bCanonical exit: 28 Aug 2022 (T+90)
- 100 shares@ SEK 91.90100.0% of flowAktieISIN SE0008015259FI:csv-98facd881af73cd1bb62Canonical exit: 2 Aug 2021 (T+90)
- 1,650 shares@ SEK 95.2614.7% of flowAktieISIN SE0008015259FI:csv-a2f1ecd59a48c6a29ce0Canonical exit: 2 Aug 2021 (T+90)
- 1,500 shares@ SEK 96.701.9% of flowAktieISIN SE0008015259FI:csv-d5d658c98e81ff4bcab1Canonical exit: 2 Aug 2021 (T+90)
- 100,000 shares@ SEK 93.30100.0% of flowAktieISIN SE0008015259FI:csv-e75372f13f2559e0b4c3Canonical exit: 2 Aug 2021 (T+90)
- 4,000 shares@ US$11.25100.0% of flowAktieISIN SE0008015259FI:csv-a6ab3482241e610c8f5aCanonical exit: 2 Aug 2021 (T+90)
- 3,500 shares@ SEK 100.0032.9% of flowAktieISIN SE0008015259FI:csv-defcbb10ef0d928c5a06Canonical exit: 24 Jun 2021 (T+90)
- 400 shares@ SEK 103.004.7% of flowAktieISIN SE0008015259FI:csv-82a4f41a3ac6383a5990
- 400 shares@ SEK 104.504.8% of flowAktieISIN SE0008015259FI:csv-10acac0e6a5cdd766946Canonical exit: 10 Jun 2021 (T+90)
- 19,412 shares@ SEK 1.773.9% of flowTeckningsoptionFI:csv-0675be25d76a8b00ef6cCanonical exit: 10 Jun 2021 (T+90)
- 4,294 shares@ SEK 4.86442.7% of flowTeckningsoptionFI:csv-f04bf12adc37ea123bb6Canonical exit: 3 Mar 2021 (T+90)
- 23,706 shares@ SEK 4.864420.5% of flowTeckningsoptionFI:csv-24624cf8b9d17d99a029Canonical exit: 3 Mar 2021 (T+90)
- 23,706 shares@ SEK 4.864410.5% of flowTeckningsoptionFI:csv-8b27166a432f7b429df9Canonical exit: 3 Mar 2021 (T+90)
- 39,851 shares@ SEK 4.86442.5% of flowTeckningsoptionFI:csv-c3940884afa7556b0af5Canonical exit: 3 Mar 2021 (T+90)
- 16,294 shares@ SEK 14.237620.7% of flowTeckningsoptionFI:csv-4b63a1b70196581b9243Canonical exit: 29 Dec 2020 (T+90)
- 16,294 shares@ SEK 14.237640.4% of flowTeckningsoptionFI:csv-3465843f0b8859f0b068Canonical exit: 29 Dec 2020 (T+90)
- 16,294 shares@ SEK 14.237629.7% of flowTeckningsoptionFI:csv-3b241cd3a6a9ad0a37e3Canonical exit: 29 Dec 2020 (T+90)
- 50,000 shares@ SEK 0.34737.2% of flowTeckningsoptionFI:csv-9e6d1a35213fe7df21b1Canonical exit: 21 Jun 2020 (T+90)
- 863 shares@ SEK 72.0026.8% of flowAktieISIN SE0008015259FI:csv-57e4db3efd8a7361b447Canonical exit: 14 Jun 2020 (T+90)
- 2,137 shares@ SEK 72.100166.0% of flowAktieISIN SE0008015259FI:csv-8ad802c1ef8f6810b1b3Canonical exit: 16 Jun 2020 (T+90)
- 35,000 shares@ SEK 213.0093.2% of flowAktieISIN SE0008015259FI:csv-9e83a9c6dd43bf9ef4d4
- 340 shares@ SEK 120.505.3% of flowAktieISIN SE0008015259FI:csv-341f4dc3d7d40887ebfeCanonical exit: 19 Feb 2019 (T+90)
- 2,459 shares@ SEK 95.0031.9% of flowISIN SE0010713958FI:csv-1c73c6a55fc0e772d3cc
25 of 36 declarations
About Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB is a company focused on developing bacterial therapies for infants. It is listed on the XSTO stock exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
